Group items matching

in title, tags, annotations or url

Happy Birthday Wishes For Special Friend | Happy Birthday Wishes For Your Special Friend https://youtu.be/xaHhsY9JdpE ------------------------------------------------------------------------------------------------------ Support us by giving a thumbs up and Subscribe this channel https://www.youtube.com/channel/UCfCp... ----------------------------------------------------------------------------------------------------------- Full Collection of Unique and Amazing wishes videos https://www.youtube.com/channel/UCfCp... ------------------------------------------------------------------------------------------------- We Eleswhere:- Google Plus: https://plus.google.com/u/0/100086217... Facebook: https://web.facebook.com/wishesready/ Twitter: https://twitter.com/wishesready Linkedin: https://www.linkedin.com/in/wishesready/ Blogspot: https://wishesready.blogspot.com/ Tumblr: https://www.tumblr.com/blog/wishesready Plurk: https://www.plurk.com/Wishesready Pinterest: https://www.pinterest.com/wishesready/ scoop: http://www.scoop.it/u/wishesready Digg: http://digg.com/u/wishesready Medium: https://medium.com/@wishesready Myspace: https://myspace.com/wishesready Diigo: https://www.diigo.com/profile/wishesr... VK: https://vk.com/wishesready Stumbleupon: https://www.stumbleupon.com/stumbler/... ------------------------------------------------------------------------------------------------------- Please support us by Subscribing our Channel. Give us a thumbs up and comment below to show your love. Thank you for standing by!

Poor communication can be frustrating; however, in healthcare, poor communication can affect a person's quality of life and length of life. Each week, patients, pharmacies, physician offices, hospitals, and patient advocacy groups receive thousands of pharmaceutical materials and related drug information that either supports or complicates patient care and the conversations patients have with their healthcare providers. Your organization may have dozens or hundreds of pieces of pharmaceutical content lying around--some of it great and some of it dangerously unclear. For us to ensure pharmaceutical communications are as clear as possible, we need your help! To keep patients as safe as possible, P.Voxx collects, digitizes, and uploads drug-related communications in a search-ready, subscription-based database. IHA plain language experts then (1) evaluate these biopharmaceutical communications for clarity and (2) work with the original content developers to make the communications more understandable. By ensuring prescription drug communications are as clear as possible, HELP empowers medication-focused programs, professionals, and patients to achieve better health outcomes How Can You Help? You can collect and donate all of the pharmaceutical marketing and advertising materials your office receives from drug reps and other sources. We send you pre-addressed, postage-paid envelopes, so you can simply place these promotional materials into the envelopes and mail them back to us. P.Voxx and the IHA will take it from there! It takes a village to gather examples of good and bad communications. We cannot do it without the help of great people like you. To know more about it, please visit our website yourhealthliteracy.org You can help save and change patients' lives! Start now!

Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices. A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role. Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an 'at home' collection pilot service for growth hormone pens. The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical company said.

A pharmacy in Derby is to reopen a year after its closure sparked more than 600 worried residents to sign a petition demanding it stayed open. An old LloydsPharmacy store on Main Drive in Chaddesden is to be the new home for Vision Pharmacy which currently has a branch at nearby Nottingham Road. Vision Pharmacy, which has been based in Chaddesden for nine years, is to move to Main Drive from the beginning of December. It means that Chaddesden will once again have a pharmacy right next to The Park Medical Practice - one of the main GP surgeries in the area - making it ideal for patients as they will simply have to just visit next door to collect prescriptions and medicines. Huge banner signs can be seen on both the existing Vision Pharmacy store and its new Main Drive premises saying the move will take place from December 1.

As part of its inclusion and diversity strategy, the Royal Pharmaceutical Society (RPS) has launched a campaign to challenge barriers to working in pharmacy for those with disabilities. A profession-wide survey on the subject conducted by the RPS, identified disability as the biggest barrier to working in pharmacy, highlighting the area of work to support pharmacists. The campaign will focus on reducing barriers to enter the profession, developing more accessible working environments and encouraging employers to collect data on disability in the workplace. The campaign, based on inputs from the RPS Ability Group volunteers with visible and non-visible disabilities, will run until the end of March. Following recommendation of the RPS Ability Group, RPS has written to the General Pharmaceutical Council (GPhC) the Higher Education Occupational Practitioners (HEOPS) to update the guidance on standards of medical fitness for pharmacy students.

Bas Vorsteveld, who was made vice president and general manager for Great Britain & Ireland (GBI) in November last year, is joined by Monica Michalopoulou as GBI marketing director and Onyeka Anugwom as GBI commercial excellence director GSK Consumer Healthcare. He took over from Jonathan Workman, who held the position from 2018, and has now moved into the role of Business Unit general manager for Northern Europe. Vorsteveld, who has 15 years' industry experience, played at major part in the merger of Novartis and GSK consumer healthcare businesses. Most recently, he held the role of VP & head of commercial excellence EMEA LATAM at GSK Consumer Healthcare, where he spearheaded international sustainability initiatives. Commenting on his new role, Vorsteveld said: "I am incredibly honoured to have been a part of GSK Consumer Healthcare's journey to date and it is our collective ambition to deliver better everyday health with humanity for our customers, with a laser focus on 'self-care'. "The recent pandemic has shown us that healthcare matters more now than ever before for our consumers. We want to redefine the role that self-care plays in people's lives, because it can bring long-term benefits for individuals and society, and is a key component of a sustainable healthcare system.

Advanz Pharma, alongside London-based private equity firms Cinven and HgCapital, is collectively confronted with an £84 million penalty for inflating the price of the thyroid drug by over 1,000 per cent, soaring from £20 to £248 per package over an eight-year period. The Competition Appeal Tribunal endorsed 'all key aspects' of the Competition and Markets Authority's verdict on the companies' culpability in the case, the CMA has said. Advanz stood as the sole supplier of liothyronine tablets, essential for treating thyroid hormone deficiency, with the cost of a packet of these tablets surging over 12-fold between 2009 and 2017. Although Advanz Pharma currently possesses ownership of the company, its former owners, PE firms Cinven and HgCapital, also bear responsibility for the imposed fine, the CMA said. "NHS annual spending on the tablets in 2006, the year before the implementation of the strategy, was £600,000, but by 2009 had increased to more than £2.3 million and jumped to more than £30 million by 2016," Britain's competition watchdog said.

The price concession for Atorvastatin 80mg has been increased to £3.91 from the previously set £3.45 for prescriptions dispensed in July, the Community Pharmacy England has said. The Department of Health and Social Care additionally introduced a concession price of £3.38 for Atorvastatin 20mg. "In July, our Dispensing and Supply Team experienced an unusually high influx of reports from pharmacies struggling to acquire Atorvastatin 80mg tablets at the listed Drug Tariff price," said CPE. CPE requested a price concession early in the month. However, after extended discussions, an agreement on the price wasn't reached. Consequently, on July 31st, the DHSC imposed a concession of £3.45. Addressing enduring pharmacy concerns over the pricing, CPE intensified advocacy with DHSC. This endeavour resulted in the revision of the Atorvastatin 80mg tablet concession price to £3.91 for prescriptions submitted and dispensed in July. According to CPE, this adjusted price sufficiently covers costs as reported by the majority of pharmacy owners. However, DHSC has refrained from modifying concessionary prices for the other two requested lines by CPE. DHSC communicated that their team's data collection for July, employing real-time sales and volume data, was incongruent with the adjustment of these prices, CPE further said.

The Association of Independent Multiple Pharmacies (AIMp) has called upon all pharmacy organisations to unite and collectively represent the sector. While underlining the need for the sector to adopt a straightforward manifesto that can be presented to the public, politicians, and decision-makers, the association also advocated for a revitalisation of the 'Save Our Pharmacies' campaign, injecting it with renewed energy and a stronger sense of purpose. AIMp pointed out that a lack of cohesion is one of the factors contributing to the sector's struggle in gaining attention. "The current trajectory of community pharmacy is unsustainable," said Dr. Leyla Hannbeck, Chief Executive of AIMp. "To tackle the significant challenges ahead, we must work together cohesively. The most effective approach is to actively engage with Parliament, leveraging politicians from across the political spectrum to advocate for our cause." Meanwhile, the association urged various pharmacy bodies to unite in support of the Pharmacy All Party Parliamentary Group (APPG) to enhance its effectiveness and broaden its influence, rather than working independently.

The Association of Pharmacy Technicians UK (APTUK) has urged the General Pharmaceutical Council (GPhC) to collate the data on actively enrolled on an approved course or qualification for Pharmacy Technicians of commencement of training. In a letter from Nicola Stockmann, Vice President APTUK to the GPhC to encourage the collection of data for Pre-Registration Training Pharmacy Technicians, Stockmann said: "We value the GPHC data for Pharmacy Technician registrants to track the growth and diversity of the Pharmacy Technician profession. With ongoing inclusive pharmacy practice priorities, APTUK has an organisational pledge to continue this work of all themes through actions. The demographics of the Pharmacy Technician workforce continue to have a majority of white British registrants and identifying as female; the high-level data collated which is currently available on the GPHC website does not capture those who are actively enrolled on an approved course or qualification for Pharmacy Technicians."

NHS England has urged the pharmacy owners to continue to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority (NHSBSA) for Quarter 4 (Q4) 2022/23 (January to March 2023). Community Pharmacy England have agreed with NHS England that the quarterly returns will continue to be on a voluntary basis, with Q4 (January to March 2023) as the second quarter to be reported. It has thanked all the members that submitted NMS quarterly summary data for Quarter 3. The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic. "NHS England wants to continue collection of the quarterly returns to provide baseline data to support a long-term evaluation that will be conducted as part of ongoing work to expand the scope of NMS," said Community Pharmacy England. Voluntary submissions can be made via the NHSBSA website, where an updated reporting spreadsheet is also available for head offices to use who are able to submit data on behalf of multiple pharmacies.

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and recycling initiative. NHS Trusts and community pharmacies participating in the new scheme will have specialised recycling containers for inhalers installed to simplify public participation, Grundon said in a statement. Inhalers alone contribute to 4 per cent of NHS CO2 emissions, with around 73 million dispensed annually. By 2026, the health service aims to achieve a 50 per cent reduction in carbon emissions from waste management, a target that rises to 80 percent between 2028 and 2032, as outlined in the NHS Clinical Waste Strategy. "This scheme holds the potential to revolutionise the approach of NHS Trusts towards achieving heightened carbon savings and ultimately, net zero emissions," said Chris Edwards, Grundon's General Manager - Technical. "Each discarded pressurised Metered Dose Inhaler (pMDI) contains highly polluting hydrofluorocarbon (HFC) gases - a category of greenhouse gas known to be over a thousand times more detrimental than carbon dioxide in driving climate change." "This initiative securely captures these gases and repurposes them for application in the refrigeration sector. By also recycling the plastic and aluminium components of the device, we are making a noteworthy contribution to the circular economy," he added. Once collected, these will undergo processing at Grundon's specialist recycling facility in Ewelme, Oxfordshire, which is capable of handling more than 200,000 inhalers a day. The company aims to recycle 80 per cent of all prescribed inhalers by 2025, the statement added.

Three pharmacists have collectively acquired Leyton Green, a community pharmacy on the outskirts of London Borough, as its owner, Raj Baxi, opts to retire after 15 years of service. The pharmacy, which processes an average of 2,697 items per month, was recently sold for an undisclosed sum, said Christie & Co, who facilitated the confidential transaction. The trio, led by Abdus Subhan, intends to drive the business forward by expanding the range of items and introducing advanced services. "After nearly 15 years in Walthamstow, we will miss our loyal customers, but we are pleased for the pharmacy to go to experienced operators," Baxi said.

The National Health Service said that over 425,000 patients have utilised its new national online service to complete GP registration within its inaugural year. The GP surgery registration service, managed by NHS England, has granted NHS patients efficient and user-friendly access to GP registration since its inception in August 2022. According to the NHS, more than 1,400 GP surgeries, a fifth of the national count, have joined the NHS online registration service as part of a new plan to improve access to primary care. "This aligns with a new strategy to enhance primary care access, with a target of enrolling 2,000 practices in the Register with a GP surgery service by December 2023." Many GP surgeries still use paper forms, requiring patients to visit surgeries to collect paperwork. However, the new online service has been shown to save GP surgery staff up to 15 minutes per registration by helping to reduce paperwork and admin time, the NHS said. The NHS said that this service enables patients to register with a local GP online at any time, eliminating the need for in-person visits and simplifying the process for both patients and GP surgeries.

More than three quarters of British people, who have suffered persistent ill health following a Covid-19 infection, have had to cut back or change the work they do, according to a survey on the impact of long Covid published on Wednesday (November 9). In the survey of 1,002 people, conducted by market research company Censuswide, some 98 per cent of long Covid sufferers said the condition had limited their ability to work, with 78 per cent needing to cut back or change their work and 19 having ceased work altogether. Long Covid, a collection of symptoms ranging from pain and heart palpitations to insomnia and brain fog, can last for many months after initial infection. Britain's most recent official labour market data showed that a record proportion of people classified as "economically inactive" - neither working nor looking for a job - were suffering from long-term sickness. In absolute terms, the number of working-age people who are long-term sick has risen by 378,000 since early 2020.

Digital transformation is sweeping across the healthcare landscape. Fuelled by ambitious government policy, exciting innovation and huge injections of funding, it's hard for anyone in the sector not to catch a dose of digitisation fever. But digitisation is not a universal tonic, and it certainly isn't always a 'good thing'. In fact, there's a real danger to digitising healthcare. Such a fundamental change to the very nature of care delivery is an inevitably high-risk process: sometimes things or people get forgotten, vital processes stall, or new systems fail to replicate the strengths of those they replace. Take, for instance, the digitisation of pharmacies. Over recent years, the public's use of online-only pharmacies have boomed: in March it was reported that the number of items dispensed from distance-selling pharmacies in England, UK quadrupled between 2016 and 2021. These online providers offer an attractively convenient way for patients to receive their medicines; replacing a trip to a high street pharmacy with a package delivered straight to their door. On the surface, this digital solution seems perfect not only for young patients with busy schedules, but also for older patients or for those with restricted mobility who may struggle with in-person collection.

Pharmacists working in Northern Ireland think the retention fees are too high, and most would prefer to pay in instalments, if that option is available, amid the increased living costs, a new survey has found. 97 per cent of the respondents to the survey, conducted by the Pharmacists' Defence Association (PDA) of its Northern Irish members, felt the fees were too high. Four in five said they would opt to pay in instalments if this option were available to them in light of the challenges of significant one-off payments. On average, the fees accounted for 23 per cent of a pharmacist's take-home pay for one month, and 98 per cent did not see any value added to their professional standing for the sum, according to the survey. The PDA said the respondents also reported feeling disadvantaged among their colleagues in terms of how fees are collected, with many also wondering why the registration fee was not offset for those on maternity leave or working reduced or flexible hours.

An ever-increasing emphasis is being placed on getting and staying fit and mobile, whatever your age, with good reason. Regular aerobic exercise (physical activity which gets the heart beating faster) helps patients to: Reduce or maintain body weight Reduce the risk of heart disease, strokes and diabetes Control blood sugar (helpful for diabetics) Maintain mobility and muscle strength, allowing daily activities to be undertaken more easily Improve mood, physical activity can be beneficial for everyone. However, injuries sometimes happen during exercise or everyday life. Collectively, injuries to tendons, ligaments and/or skeletal muscle, are referred to as musculoskeletal soft tissue injuries. Post pandemic pharmacists are now the first port of call for many seeking to self-treat so it is important that information, advice and a wide range of treatment options are available. While the precise incidence and prevalence of such disorders are difficult to define, they are known to be the most common rheumatic causes of sickness absences from work. Indeed, soft tissue complaints account for up to 59 per cent of new patient referrals to rheumatology practice and up to 15 per cent of consultations in primary care. Ankle injuries are very common with an estimated incidence of one per 100,000 population per day. They account for about one in five of all sports related injuries. The majority of ankle injuries are moderate ligament sprains. With appropriate treatment the majority of patients should be able to return to normal activities within a few weeks.

The Pharmacists' Defence Association (PDA) has become a member of the International Pharmaceutical Federation (FIP). On Thursday (22 September), the FIP council voted to welcome the PDA as a full member of the global federation of organisations that brings together and advances pharmacy. Mark Koziol, PDA chairman, said: "Being admitted to FIP with such a decisive level of support from its Council means that the PDA can ensure that UK pharmacists can enjoy a clear and powerful voice representing their collective professional interests at global level, which of late they could not. "Bringing one of the largest pharmacy membership organisations in the world to FIP also gives the PDA significant influence in being able to inform the policies of the World Health Organisation. This means that the PDA can do even more for members by helping to make pharmacy practice more professionally fulfilling for them." "The PDA constantly seeks ways to provide even better support for members; membership of FIP will give the PDA much more influence and will result in better outcomes for pharmacists," the association said. To support humanitarian crises in other parts of the world, the PDA approached FIP, as a global pharmacy leadership organisation.

Will Quince, MP for Colchester and Health Minister visited Rowlands pharmacy on Friday (20 January) in Nayland Road in his constituency. The important role played by pharmacies in providing NHS care, support, and advice helping the local community to live healthier lives and manage long-term conditions were discussed among the pharmacy teams. Mr Quince said: "Community pharmacy is playing an increasingly important role in ensuring people in Colchester have convenient walk-in access to the healthcare support and advice they need. Pharmacies are not simply places to collect prescriptions, they provide a wide range of services and are the third pillar of access to primary care alongside GPs and A&E. I would urge people to think pharmacy first if they have a minor ailment; need advice on taking their medication; want to stop smoking or want to check their blood pressure."